20
Participants
Start Date
June 11, 2024
Primary Completion Date
February 26, 2025
Study Completion Date
September 30, 2025
RHA® Redensity with new anesthetic agent
A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus zooepidemicus, formulated to a concentration of 15 mg/g and 0.3% w/w of new anesthetic agent in a physiologic buffer.
RHA® Redensity with lidocaine
A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus zooepidemicus, formulated to a concentration of 15 mg/g and 0.3% w/w lidocaine in a physiologic buffer.
United States, New York, New York
United States, Birmingham
Puerto Rico, San Juan
Teoxane SA
INDUSTRY